NCT04814186 A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Status COMPLETED Phase PHASE4
NCT04804033 A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention Status TERMINATED Phase PHASE2/PHASE3
NCT04803305 Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia Status COMPLETED Phase PHASE1
NCT04801589 Goal-Directed Sedation in Mechanically Ventilated Infants and Children Status RECRUITING Phase PHASE3
NCT04801420 Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population Status COMPLETED Phase PHASE2
NCT04801329 Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04800185 Characterizing Skin Microbiome Change in Atopic Dermatitis Status COMPLETED Phase EARLY_PHASE1
NCT04798586 MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT04793399 Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients Status TERMINATED Phase PHASE1/PHASE2
NCT04785612 Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults Status COMPLETED Phase PHASE2
NCT04774094 Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP) Status COMPLETED Phase PHASE4
NCT04767594 First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04766086 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women Status COMPLETED Phase PHASE2
NCT04764487 A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line Status UNKNOWN Phase PHASE3
NCT04756765 Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer Status WITHDRAWN Phase PHASE2